Molecular Templates Received Nasdaq Notices For Non-Compliance Due To Delinquent Filing Of Q3 Report And Minimum Bid Price Below $1, With Deadlines To Regain Compliance By May 2025 And Potential Delisting Consequences; The Company Has Until January...

Molecular Templates 收到納斯達克關於不合規的通知，原因是未按時提交第三季度報告以及最低買盤價格低於1美元，要求在2025年5月之前恢復合規，否則可能會面臨退市後果；該公司必須在1月之前

Benzinga · 11/27 05:39

Molecular Templates Received Nasdaq Notices For Non-Compliance Due To Delinquent Filing Of Q3 Report And Minimum Bid Price Below $1, With Deadlines To Regain Compliance By May 2025 And Potential Delisting Consequences; The Company Has Until January 24, 2025 To Submit A Plan To Regain Compliance With Respect To The Delinquent Filing

Molecular Templates 收到納斯達克關於不合規的通知，原因是未按時提交第三季度報告以及最低買盤價格低於1美元，要求在2025年5月之前恢復合規，否則可能會面臨退市後果；該公司必須在2025年1月24日之前提交計劃，以恢復與逾期提交相關的合規性

- SEC Filing

- SEC文件

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。